top of page
LIfT BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the World Leader in Neutrophil Immunotherapies
London, 13 March 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil...
Mar 13, 2025
LIfT BioSciences expands into Ireland for manufacturing & clinical operations
LIfT BioSciences expands into Ireland for manufacturing & clinical operations London, 18 November 2024– LIfT BioSciences, (‘LIfT’ or ‘the...
Nov 18, 2024
G-Rex® Grant awarded to LIfT Bio
Award will support clinical manufacturing of the Company’s promising Neutrophil only Leukocyte Infusion Therapy (N-LIfT) platform
Oct 9, 2024
bottom of page